Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006989
Filing Date
2025-05-08
Accepted
2025-05-08 16:30:04
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20250331x10q.htm   iXBRL 10-Q 1845746
2 EX-31.1 gpcr-20250331xex31d1.htm EX-31.1 16142
3 EX-31.2 gpcr-20250331xex31d2.htm EX-31.2 16239
4 EX-32.1 gpcr-20250331xex32d1.htm EX-32.1 9842
5 EX-32.2 gpcr-20250331xex32d2.htm EX-32.2 10129
6 GRAPHIC gpcr-20250331x10q001.jpg GRAPHIC 99163
  Complete submission text file 0001558370-25-006989.txt   6416486

Data Files

Seq Description Document Type Size
7 EX-101.SCH gpcr-20250331.xsd EX-101.SCH 35202
8 EX-101.CAL gpcr-20250331_cal.xml EX-101.CAL 43929
9 EX-101.DEF gpcr-20250331_def.xml EX-101.DEF 141078
10 EX-101.LAB gpcr-20250331_lab.xml EX-101.LAB 324344
11 EX-101.PRE gpcr-20250331_pre.xml EX-101.PRE 233093
59 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20250331x10q_htm.xml XML 877932
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 25926750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)